Oral contraceptives, commonly known as birth control pills, are among the most widely used medications by women worldwide. For decades, these hormone-based pills have helped women prevent unwanted pregnancies, regulate menstrual cycles, manage hormonal conditions and improve quality of life. Their effectiveness and convenience have made them one of the most popular forms of contraception.
However, questions about the long-term health effects of birth control pills continue to generate discussion among doctors, researchers and patients. One area that has received significant scientific attention is the relationship between oral contraceptive use and cancer risk.
Research over several decades has shown that the connection between birth control pills and cancer is not straightforward. Rather than simply increasing or decreasing cancer risk overall, oral contraceptives appear to have different effects on different types of cancer. Studies suggest that while the pills may slightly increase the risk of some cancers, they may significantly reduce the risk of others.
Experts stress that understanding both the risks and benefits is important for women making informed decisions about contraception and long-term health.
WHAT DOES THE RESEARCH SAY?
Most of the evidence linking oral contraceptives and cancer comes from large observational studies that have followed women over many years.
Overall, research suggests that women who use oral contraceptives may experience:
-
A slight increase in the risk of breast cancer
-
An increased risk of cervical cancer with long-term use
-
A lower risk of endometrial cancer
-
A lower risk of ovarian cancer
-
A lower risk of colorectal cancer
The effects vary depending on the duration of use, the type of pill and individual health factors.
Dr Parminder Kaur, Consultant Gynaecologic Oncologist, CK Birla Hospital, Delhi, says that oral contraceptives are among the most extensively studied medications worldwide, but their relationship with cancer is often misunderstood.
“One of the most significant benefits of oral contraceptive use is the reduction in the risk of several cancers. Studies have consistently shown that women who use oral contraceptives have a 30–50% lower risk of ovarian cancer and approximately a 30% lower risk of endometrial cancer compared to never-users. Evidence also suggests a modest reduction in colorectal cancer risk. At the same time, current or recent users may experience a modest increase in the risk of breast and cervical cancers. However, the absolute increase in risk remains small for most women, and the elevated risk generally declines over time after stopping the pills,” she explains.
Dr Kaur adds that decisions about hormonal contraception should take into account individual factors such as age, family history, genetic predisposition, medical conditions, lifestyle, and reproductive goals.
- Breast cancer: Research has shown that current users may have a modest increase in risk. However, the risk appears to decline after stopping the pills, and studies suggest that it returns to normal over time. A large Danish study also found that the risk increased slightly with longer duration of use.
- Cervical cancer: Long-term use (5 years or more) of oral contraceptives may increase cervical cancer risk. However, the risk tends to decline after stopping the pills. Persistent high-risk HPV infection remains the main cause of cervical cancer.
- Endometrial cancer: Women who use birth control pills may have about a 30% lower risk of endometrial cancer. The protective effect increases with longer use and can last for years after discontinuation.
- Ovarian cancer: Oral contraceptives are linked to a 30–50% lower risk of ovarian cancer. Protection strengthens with longer use and may continue for decades after stopping the medication.
- Colorectal cancer: Studies suggest birth control pills may reduce colorectal cancer risk by approximately 15–20%. Researchers are still studying the exact reasons behind this protective effect.
WHY CAN BIRTH CONTROL PILLS AFFECT CANCER RISK?
Scientists believe the answer lies in hormones.
Oestrogen and progesterone naturally influence the growth and development of certain tissues in the body. Because oral contraceptives contain synthetic versions of these hormones, they may affect cancer risk in hormone-sensitive organs.
Researchers have proposed several mechanisms that may explain the reduced risk of ovarian, endometrial and colorectal cancers, including fewer lifetime ovulations and reduced stimulation of specific tissues.
Oral contraceptives have transformed reproductive healthcare and continue to be used safely by millions of women worldwide. Research suggests that while birth control pills may slightly increase the risk of breast and cervical cancers, they also offer substantial protection against ovarian, endometrial and colorectal cancers.
Explaining the biological link, Dr Swati Sinha, Senior Consultant – Obstetrics & Gynaecology, Rosewalk by Rainbow Hospitals, says hormones in oral contraceptives can influence cancer risk in different ways.
Oral contraceptives contain synthetic versions of hormones such as oestrogen and progesterone, which influence several biological processes throughout the body. Because certain cancers are hormone-sensitive, researchers have long studied how hormonal contraceptives may affect cancer risk over time,” she says.
“The impact is not uniform across all cancers. Hormonal exposure may stimulate the growth of some hormone-responsive tissues, which could partly explain the observed association with a slightly increased risk of breast cancer. Conversely, oral contraceptives can lower the risk of several gynaecological cancers. By suppressing ovulation, they reduce repeated injury and repair cycles in the ovaries, which may decrease ovarian cancer risk. They also help regulate excessive endometrial cell proliferation, contributing to a lower likelihood of endometrial cancer. Evidence additionally suggests a protective effect against colorectal cancer.”
Dr Sinha emphasises that oral contraceptives do not simply increase or decrease cancer risk overall. “They alter risk patterns in different ways, which is why decisions regarding contraceptive use should be individualised and made in consultation with a healthcare provider.”
Rather than viewing the pill as simply “good” or “bad,” experts say women should understand both sides of the evidence. Informed discussions with healthcare providers remain the best way to choose the contraceptive method that aligns with individual health needs and long-term goals.
– Ends